Inventor
Duane DeMong
Inventor
Somerset, NJ, US
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds43%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes26%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
10,968,193Antidiabetic bicyclic compounds202110,954,240Compounds inhibiting leucine-rich repeat kinase enzyme activity202110,806,724Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative allosteric modulators, compositions, and their use202010,793,557Sting agonist compounds202010,662,171Antidiabetic bicyclic compounds202010,335,399Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2--negative allosteric modulators, compositions, and their use201910,131,651[7,6]-fused bicyclic antidiabetic compounds201810,100,042[5,6]--fused bicyclic antidiabetic compounds201810,059,667Antidiabetic compounds20189,840,512'Antidiabetic bicyclic compounds'20179,809,568'Compounds inhibiting leucine-rich repeat kinase enzyme activity'20179,718,818'Compounds inhibiting leucine-rich repeat kinase enzyme activity'20179,688,654'Compounds inhibiting leucine-rich repeat kinase enzyme activity'20179,493,440'Compounds inhibiting leucine-rich repeat kinase enzyme activity'20169,440,952'Compounds inhibiting leucine-rich repeat kinase enzyme activity'20169,416,126'Compounds inhibiting leucine-rich repeat kinase enzyme activity'20169,006,228'Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment'20158,957,062'Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment'20158,735,604'Pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use'20148,633,231'Substituted imidazolones, compositions containing such compounds and methods of use'20148,623,818'Glucagon receptor antagonists, compositions, and methods for their use'20148,623,873'Substituted piperazines as CB1 antagonists'20148,361,959'Spiro-imidazolone derivatives as glucagon receptor antagonists'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2013–2021Patents assigned to MERCK SHARP & DOHME (22)· patent assignee history
2013–2015Patents assigned to MILLER MICHAEL W (6)· patent assignee history
2013–2015Patents assigned to STAMFORD ANDREW (5)· patent assignee history
2013–2017Patents assigned to DAI XING (4)· patent assignee history
2013–2018Based in Somerset, NJ, US· patent location history
2014–2018Patents assigned to DEMONG DUANE (4)· patent assignee history
2018–2021Based in Hanover, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 22 | 2013–2021 |
| MILLER MICHAEL W | 6 | 2013–2015 |
| STAMFORD ANDREW | 5 | 2013–2015 |
| DAI XING | 4 | 2013–2017 |
| DEMONG DUANEself | 4 | 2014–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Somerset, New Jersey, US | 15 | 2013–2018 |
| Hanover, Massachusetts, US | 8 | 2018–2021 |